DE69734601D1 - Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen - Google Patents

Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen

Info

Publication number
DE69734601D1
DE69734601D1 DE69734601T DE69734601T DE69734601D1 DE 69734601 D1 DE69734601 D1 DE 69734601D1 DE 69734601 T DE69734601 T DE 69734601T DE 69734601 T DE69734601 T DE 69734601T DE 69734601 D1 DE69734601 D1 DE 69734601D1
Authority
DE
Germany
Prior art keywords
compositions
binding protein
prevention
cna
dna segments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69734601T
Other languages
English (en)
Other versions
DE69734601T2 (de
Inventor
Magnus Hoeoek
M Patti
Karen House-Pompeo
Narayana Sthanam
Jindrich Symersky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas A&M University System
UAB Research Foundation
Original Assignee
Texas A&M University System
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A&M University System, UAB Research Foundation filed Critical Texas A&M University System
Publication of DE69734601D1 publication Critical patent/DE69734601D1/de
Application granted granted Critical
Publication of DE69734601T2 publication Critical patent/DE69734601T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69734601T 1996-05-16 1997-05-14 Zusammensetzung von kollagenbindungsprotein und verfahren zu deren verwendungen Expired - Fee Related DE69734601T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1767896P 1996-05-16 1996-05-16
US17678P 1996-05-16
PCT/US1997/008210 WO1997043314A2 (en) 1996-05-16 1997-05-14 Collagen binding protein compositions and methods of use

Publications (2)

Publication Number Publication Date
DE69734601D1 true DE69734601D1 (de) 2005-12-15
DE69734601T2 DE69734601T2 (de) 2006-08-03

Family

ID=21783969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734601T Expired - Fee Related DE69734601T2 (de) 1996-05-16 1997-05-14 Zusammensetzung von kollagenbindungsprotein und verfahren zu deren verwendungen

Country Status (9)

Country Link
US (2) US6288214B1 (de)
EP (1) EP0950068B1 (de)
AT (1) ATE309271T1 (de)
AU (1) AU3126097A (de)
CA (1) CA2255669A1 (de)
DE (1) DE69734601T2 (de)
DK (1) DK0950068T3 (de)
ES (1) ES2252785T3 (de)
WO (1) WO1997043314A2 (de)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309271T1 (de) * 1996-05-16 2005-11-15 Texas A & M Univ Sys Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
WO2000012132A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
ES2322409T3 (es) * 1998-08-31 2009-06-19 Inhibitex, Inc. Vacunas multicomponentes contra staphylococcus aureus.
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
CA2503110A1 (en) 1999-05-10 2000-11-16 Rebecca L. Rich Collagen-binding proteins from enterococcal bacteria
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
AU4933799A (en) 1999-08-02 2001-02-19 E-Mark Systems Inc. Electronic settlement system, settlement device, and terminal
US20070077256A1 (en) * 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
AU2001256958A1 (en) 2000-03-17 2001-10-03 Inhibitex, Inc. Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
ATE524195T1 (de) * 2001-01-26 2011-09-15 Inhibitex Inc Monoklonale antikörper gegen das clfa-protein und verfahren zur verwendung bei der behandlung bzw. pr vention von infektionen
JP2002253712A (ja) * 2001-03-02 2002-09-10 Endo Mfg Co Ltd ゴルフクラブ
EP1443957A4 (de) * 2001-05-08 2005-10-12 Texas A & M Univ Sys Oberflächenproteine aus grampositiven bakterien mit hochkonservierten motiven sowie diese erkennende antikörper
EP1395272A4 (de) 2001-05-11 2005-10-26 Texas A & M Univ Sys Verfahren und zusammensetzungen zur hemmung der durch thrombin induzierten blutgerinnung
CN100359327C (zh) * 2001-06-15 2008-01-02 英希比泰克斯公司 识别凝血酶阴性的葡萄球菌和金黄色葡萄球菌的表面蛋白的交叉反应性单克隆抗体和多克隆抗体
US7115264B2 (en) * 2001-11-05 2006-10-03 Inhibitex Monoclonal antibodies to the fibronectin binding protein and method of use in treating or preventing infections
US20030153026A1 (en) * 2002-01-04 2003-08-14 Javier Alarcon Entrapped binding protein as biosensors
US6855556B2 (en) 2002-01-04 2005-02-15 Becton, Dickinson And Company Binding protein as biosensors
WO2003072607A1 (en) * 2002-02-21 2003-09-04 Università Degli Studi Di Pavia Monoclonal antibodies that are cross-reactive against bacterial collagen binding proteins
WO2003076470A1 (en) * 2002-03-05 2003-09-18 Inhibitex, Inc. Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
AU2004220590B2 (en) * 2003-03-07 2010-02-18 Inhibitex, Inc. Polysaccharide - Staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
WO2005124348A1 (en) * 2004-06-09 2005-12-29 Becton, Dickinson And Company Multianalyte sensor
EP2305294B1 (de) 2004-09-22 2015-04-01 GlaxoSmithKline Biologicals SA Immunogene Zusammensetzung zur Verwendung zur Impfung gegen Staphylokokken
PL1838341T3 (pl) 2005-01-20 2014-04-30 Isconova Ab Kompozycja szczepionki obejmująca białko wiążące fibronektynę lub peptyd wiążący fibronektynę
JP4726109B2 (ja) * 2005-02-10 2011-07-20 昭和電工株式会社 皮膚外用剤、それを用いる皮膚有害微生物の付着予防方法及び増殖防止方法
JP2008532935A (ja) * 2005-02-14 2008-08-21 エピトピックス，リミティド ライアビリティ カンパニー 黄色ブドウ球菌由来のポリペプチド及び使用方法
WO2006138627A2 (en) * 2005-06-16 2006-12-28 Inhibitex, Inc. Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein
JP2009502261A (ja) * 2005-07-25 2009-01-29 ナノテクノロジー ビクトリア ピーティーワイ リミテッド マイクロアレイデバイス
WO2007030012A2 (en) * 2005-09-05 2007-03-15 Stichting Voor De Technische Wetenscahappen Extracellular matrix imaging
WO2007100580A2 (en) * 2006-02-22 2007-09-07 The Texas A & M University System Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use
EP2476434A1 (de) 2006-03-30 2012-07-18 GlaxoSmithKline Biologicals S.A. Immunogene Zusammensetzung
ES2391908T3 (es) 2006-04-20 2012-11-30 Becton,Dickinson And Company Proteinas termoestables y procedimientos de obtención y uso de las mismas
US20180221466A9 (en) * 2006-06-12 2018-08-09 Glaxosmithkline Biologicals S.A. Use of alpha-toxin for treating and preventing staphylococcus infections
CA2697538C (en) * 2007-08-31 2019-02-12 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
WO2010042481A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial eap, emp, and/or adsa proteins
AU2010204139A1 (en) 2009-01-12 2011-08-11 Novartis Ag Cna_B domain antigens in vaccines against gram positive bacteria
US9932373B2 (en) 2009-03-23 2018-04-03 Epitopix, Llc Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
JP5747370B2 (ja) * 2009-03-31 2015-07-15 国立大学法人浜松医科大学 高病原性口腔細菌の高感度検出法
KR20170102039A (ko) 2009-04-03 2017-09-06 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP2284193A1 (de) * 2009-08-10 2011-02-16 Kenta Biotech AG Menschlicher monoklonaler Antikörper gegen S.aureus aus Alpha-Toxin und seine Verwendung bei der Behandlung oder Vorbeugung der Abszessbildung
US9297811B2 (en) 2010-03-10 2016-03-29 National University Corporation Hamamatsu University School Of Medicine Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor
US8808699B2 (en) 2010-04-05 2014-08-19 The University Of Chicago Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune response
AU2011274367B2 (en) 2010-07-02 2015-04-23 The University Of Chicago Compositions and methods related to protein A (SpA) variants
WO2012034067A1 (en) 2010-09-09 2012-03-15 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US8182842B1 (en) 2010-11-10 2012-05-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
US8440618B2 (en) * 2011-01-19 2013-05-14 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Composition for the attachment of implants to collagen or other components of biological tissue
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
JP2014521605A (ja) 2011-07-22 2014-08-28 ノバダイム セラピューティクス， インコーポレイテッド Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓに対してワクチン接種するための方法および組成物
CA2845259A1 (en) 2011-08-15 2013-02-21 The University Of Chicago Compositions and methods related to antibodies to staphylococcal protein a
JP6251730B2 (ja) 2012-04-26 2017-12-20 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）疾患の間にコアグラーゼ活性を中和する抗体に関連した組成物および方法
NZ702285A (en) 2012-04-26 2016-07-29 Univ Chicago Staphylococcal coagulase antigens and methods of their use
MD20150098A2 (ro) 2013-03-15 2016-02-29 Los Angeles Biomedical Research Institute At Harbor - Ucla Medical Center Compoziţii şi procedee de tratare a agenţilor patogeni fungici şi bacterieni
US11531028B2 (en) 2013-05-10 2022-12-20 Nordic Bioscience A/S Collagen type X alpha-1 assay
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
WO2017087838A2 (en) * 2015-11-19 2017-05-26 George Mason University Dual inhibitory action peptidomimetic inhibitor for il-33 and il-1beta
EP3426287A4 (de) 2016-03-09 2020-03-11 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center Verfahren und kits zur verwendung bei der vorbeugung und behandlung von vulvovaginaler candidose
EP3870598A1 (de) 2018-10-23 2021-09-01 Dragonfly Therapeutics, Inc. Heterodimere fc-kondensierte proteine
KR20220107166A (ko) 2019-10-02 2022-08-02 얀센 백신스 앤드 프리벤션 비.브이. 스타필로코커스 펩티드 및 사용 방법
IL297495A (en) 2020-04-22 2022-12-01 Dragonfly Therapeutics Inc Dosing regimen, formulation and manufacturing process for fc fusion heterodimeric proteins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189015A (en) * 1984-05-30 1993-02-23 Alfa-Laval Agri International Ab Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability
GB8516421D0 (en) 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide
US5270030A (en) * 1988-12-29 1993-12-14 Bio-Technology General Corp. Fibrin binding domain polypeptide and method of producing
SE9003374D0 (sv) 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5851794A (en) * 1990-10-22 1998-12-22 Alfa Laval Ab Collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
US5491130A (en) 1992-11-10 1996-02-13 The United States Of America As Represented By The Department Of Health And Human Services Peptide inhibitors of fibronectin and related collagen-binding proteins
US5624904A (en) * 1993-11-17 1997-04-29 Massachusetts Institute Of Technology Method for treating gram positive septicemia
US6008341A (en) * 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
US5858709A (en) * 1996-10-15 1999-01-12 Smithkline Beecham P.L.C. Fibronectin binding protein B compounds
US6013482A (en) * 1996-10-15 2000-01-11 Smithkline Beecham Plc Cell surface protein compounds
ATE309271T1 (de) * 1996-05-16 2005-11-15 Texas A & M Univ Sys Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
US5789171A (en) * 1996-06-20 1998-08-04 Board Of Trustees Of The University Of Arkansas Use of cna, fnba, fnbb, and hlb, gene probes for the strain-specific identification of Staphylococcus aureus

Also Published As

Publication number Publication date
US6288214B1 (en) 2001-09-11
AU3126097A (en) 1997-12-05
EP0950068A2 (de) 1999-10-20
WO1997043314A2 (en) 1997-11-20
ATE309271T1 (de) 2005-11-15
WO1997043314A3 (en) 1997-12-24
DK0950068T3 (da) 2006-02-13
CA2255669A1 (en) 1997-11-20
EP0950068B1 (de) 2005-11-09
ES2252785T3 (es) 2006-05-16
DE69734601T2 (de) 2006-08-03
US20020102262A1 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
DE69734601D1 (de) Zusammensetzungen von kollagenbindungsprotein und verfahren zur deren verwendungen
RU94046367A (ru) Днк, хозяйская клетка, способ получения белка, белок, фармацевтический препарат, антитело, применение антитела
DE69032484T4 (de) Zusammensetzungen und deren verwendung zur förderung der immunopotentiation
DE60130468D1 (de) Zusammensetzungen und verfahren zur behandlung von chlamydia-infektionen
CA2340304A1 (en) Multicomponent vaccines
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
GEP20022695B (en) Moraxella Catarrhalis Outer Membrane Protein-106 Polypeptide, Gene Sequence and Uses Thereof
NZ524888A (en) Nucleic acids and proteins from streptococcus groups A & B
ATE461709T1 (de) Choline-bindende proteine derivate aus pneumokoken als impfstoff
ATE251464T1 (de) Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
ATE17082T1 (de) Verfahren zur herstellung von polysaccharidprotein-komplexenaus bakterienhuellen, die hergestellten produkte und dieselben enthaltende immunogenische zusammensetzungen.
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
PT750672E (pt) Sequencias de adn para metaloproteases matriciais, sua preparacao e utilizacao.
BR0010155A (pt) Proteìnas isolada, e quimérica, composição, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição de vacina recombinante ou composição de vacina atenuada, composição farmacêutica, métodos de imunizar um indivìduo contra um imunógeno, proteìna não-cd80 isolada, molécula de ácido nucleico, e, método de imunossuprimir um indivìduo
DE69841073D1 (de) Fibronektinbindungsprotein abgeleitete peptide, die nicht an fibronektin binden, antikörper dagegen und therapeutische anwendung
ATE237691T1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
RU94040393A (ru) Синтетические пептиды для вакцины против краснухи
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
DE69833568D1 (de) Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
FR2792639B1 (fr) Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
ATE401349T1 (de) Monoklonale antikörper gegen das map-protein und verfahren zu dessen anwendung bei der behandlung bzw. prävention von infektionen
TH64256A3 (th) องค์ประกอบของโปรตีนที่ถูกทำให้เสถียร
TH14996EX (th) วัคซีนป้องกันโรคติดเชื้อสเตร็ปโตคอคคัส ซูอิส

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee